NPS 1506, a moderate affinity uncompetitive NMDA receptor antagonist: Preclinical summary and clinical experience

Amino Acids

Volumn 19, Issue 1, 2000, Pages 177-179

  Mueller, A L ^a   Artman, L D ^a   Balandrin, M F ^a   Brady, E ^a   Chien, Y ^a   DelMar, E G ^a   Kierstead, A ^a   Marriott, T B ^a   Moe, S T ^a   Raszkiewicz, J L ^a   VanWagenen, B ^a   Wells, D ^a  

^a NPS Pharmaceutical Inc   (United States)

Author keywords

Amino acids; Glutamate; Neuroprotection; NMDA receptors

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NPS 1506; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATAXIA; CELL CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG STRUCTURE; FEMALE; GRANULE CELL; HUMAN; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VERTIGO;

ADOLESCENT; ADULT; ANIMAL; CELLS, CULTURED; CEREBRAL CORTEX; DIZOCILPINE MALEATE; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FLUOROBENZENES; HUMAN; MALE; PLACEBOS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

ANIMALIA; ATAXIA;

EID: 0033796259     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007260070047     Document Type: Short Survey

References (0)